Profil
Actuellement, Brian K. Beeler occupe le poste de vice-président exécutif et directeur juridique chez Horizon Therapeutics Plc. Au cours de sa carrière antérieure, il a été avocat-conseil principal chez TAP Pharmaceutical Products, Inc, avocat-conseil associé chez Fenwal, Inc, responsable de la conformité et vice-président chez Horizon Pharma, Inc, avocat-conseil principal chez Takeda Pharmaceuticals U.S.A., Inc et responsable de la conformité chez Schwarz Pharma, Inc. M. Beeler a obtenu un diplôme de premier cycle à l'université de Purdue, un MBA à la Kellogg School of Management et un diplôme de deuxième cycle à la Maurer School of Law de l'université d'Indiana.
Anciens postes connus de Brian Beeler
Sociétés | Poste | Fin |
---|---|---|
HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Compliance Officer | 08/05/2015 |
Fenwal, Inc.
Fenwal, Inc. BiotechnologyHealth Technology Fenwal, Inc. is a global medical technology company focused on improving transfusion medicine through expertise in blood separation, collection, filtration, storage, and transfusion. It offers apheresis collections, manual collections, therapeutics, specialty products, platelet safety, data management, data management, and customer solutions The company was founded in 1949 and is headquartered in Lake Zurich, IL. | Corporate Officer/Principal | 01/12/2012 |
TAP Pharmaceutical Products, Inc.
TAP Pharmaceutical Products, Inc. Pharmaceuticals: MajorHealth Technology TAP Pharmaceutical Products, Inc. manufactures, develops, and markets pharmaceutical products. Its services include gastroenterology, gynecology, and urology. The company was founded in 1977 and is headquartered in Lake Forest, IL. | General Counsel | 01/12/2008 |
Takeda Pharmaceuticals U.S.A., Inc.
Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL. | General Counsel | 01/12/2008 |
Schwarz Pharma, Inc.
Schwarz Pharma, Inc. Pharmaceuticals: MajorHealth Technology SCHWARZ PHARMA, Inc. develops and manufactures pharmaceutical products. The company's products include Codimal, Colyte, Edex, Kutrase, Levatol, Robaxin, and Verelan. It was founded in 2003 and is headquartered in Mequon, WI. | Compliance Officer | 01/01/2007 |
Formation de Brian Beeler
Purdue University | Undergraduate Degree |
Kellogg School of Management | Masters Business Admin |
Indiana University Maurer School of Law | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 6 |
---|---|
Horizon Therapeutics Plc
Horizon Therapeutics Plc Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Plc is a biopharmaceutical company, which engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Inflammation segments. The Orphan segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland. | Health Technology |
TAP Pharmaceutical Products, Inc.
TAP Pharmaceutical Products, Inc. Pharmaceuticals: MajorHealth Technology TAP Pharmaceutical Products, Inc. manufactures, develops, and markets pharmaceutical products. Its services include gastroenterology, gynecology, and urology. The company was founded in 1977 and is headquartered in Lake Forest, IL. | Health Technology |
Schwarz Pharma, Inc.
Schwarz Pharma, Inc. Pharmaceuticals: MajorHealth Technology SCHWARZ PHARMA, Inc. develops and manufactures pharmaceutical products. The company's products include Codimal, Colyte, Edex, Kutrase, Levatol, Robaxin, and Verelan. It was founded in 2003 and is headquartered in Mequon, WI. | Health Technology |
Fenwal, Inc.
Fenwal, Inc. BiotechnologyHealth Technology Fenwal, Inc. is a global medical technology company focused on improving transfusion medicine through expertise in blood separation, collection, filtration, storage, and transfusion. It offers apheresis collections, manual collections, therapeutics, specialty products, platelet safety, data management, data management, and customer solutions The company was founded in 1949 and is headquartered in Lake Zurich, IL. | Health Technology |
Takeda Pharmaceuticals U.S.A., Inc.
Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL. | Health Technology |
Horizon Pharma, Inc.
Horizon Pharma, Inc. Pharmaceuticals: MajorHealth Technology Horizon Pharma, Inc. discovers and develops medicines for the treatment of chronic inflammatory diseases. It is a specialty pharmaceutical company that has developed and is commercializing DUEXIS and RAYOS, both of which target unmet therapeutic needs in arthritis, pain and inflammatory diseases. The company products include DUEXIS (ibuprofen and famotidine) Tablets, is a proprietary, single-tablet combination of the non-steroidal anti-inflammatory drug ibuprofen and the histamine H2-receptor antagonist famotidine; RAYOS (prednisone) delayed-release tablets, known as LODOTRA outside the U.S., is a proprietary delayed-release formulation of low-dose prednisone for the treatment of moderate to severe, active RA in adults, particularly when accompanied by morning stiffness. Horizon Pharma was founded on March 23, 2010 and is headquartered in Deerfield, IL. | Health Technology |